FIRST AMENDMENT TO INTELLECTUAL PROPERTY SECURITY AGREEMENT (APPLIED DNA SCIENCES, INC.)Intellectual Property Security Agreement • May 9th, 2019 • Applied Dna Sciences Inc • Services-miscellaneous business services • New York
This FIRST AMENDMENT TO INTELLECTUAL PROPERTY SECURITY AGREEMENT (this “Amendment”), dated as of February 26, 2019, is between APPLIED DNA SCIENCES, INC., a Delaware corporation (the “Grantor”) and DELAWARE TRUST COMPANY, a Delaware corporation, as collateral agent (together with its successors and assigns, in such capacity, the “Collateral Agent”) for the benefit of the undersigned investors (each, a “Buyer” and collectively, the “Buyers”; the Buyers and the Collateral Agent are collectively, together with their successors and assigns, referred to herein as the “Secured Parties”) and the other Secured Parties.
OMNIBUS AMENDMENT AGREEMENTAugust Securities Purchase Agreement • May 9th, 2019 • Applied Dna Sciences Inc • Services-miscellaneous business services • New York
This OMNIBUS AMENDMENT AGREEMENT (this “Amendment”), dated as of February 26, 2019, is entered into by and among APPLIED DNA SCIENCES, INC., a Delaware corporation (the “Issuer”), APDN (B.V.I.) INC., a corporation organized under the laws of the British Virgin Islands (the “Guarantor”, and together with the Issuer, collectively, the “Grantors” and each a “Grantor”), DELAWARE TRUST COMPANY, a Delaware corporation, as collateral agent (together with its successors and assigns, in such capacity, the “Collateral Agent”) for the benefit of the Buyers (defined below) and each of the investors listed on Schedule I attached hereto (each, a “Buyer” and collectively, the “Buyers”; the Buyers and the Collateral Agent are collectively, together with their successors and assigns, collectively, the “Secured Parties”).
Portions of this exhibit have been omitted because the information is both not material and would likely cause competitive harm to the registrant if publicly disclosed. The omissions have been indicated by bracketed asterisks (“[***]”).] Patent and...License and Cooperation Agreement • May 9th, 2019 • Applied Dna Sciences Inc • Services-miscellaneous business services • New York
This Patent and Know-How License and Cooperation Agreement (the “Agreement”), dated as of March 28, 2019 (the “Effective Date”), is by and between Applied DNA Sciences, Inc., a Delaware corporation, with an address of 50 Health Sciences Drive, Stony Brook, New York 11790, APDN (B.V.I.), Inc., a fully owned subsidiary of Applied DNA Sciences, Inc. with an address of PO Box, 3170, Road Town, Tortola, British Virgin Islands (collectively “Applied DNA” or “Licensor”) and ETCH BioTrace S.A., a Panama corporation and a fully owned subsidiary of TheraCann International Benchmark Corporation, with an address of International Business Park Unit 5B, Building 3860 Panama Pacifico, Republic of Panama, 000000 (“ETCH BioTrace” or “Licensee”). Applied DNA and ETCH BioTrace shall each be referred to as a “Party” and collectively as the “Parties.”
